Oval Created with Sketch. Group Created with Sketch.
Created with Lunacy
The Firm Practices Insights & Assignments People Career Sustainability Contact

We use cookies

Moalem Weitemeyer uses cookies, including cookies from third parties, needed to make the website work and to enhance the user experience. Cookies are also used to detect inexpediencies and to examine your interactions with our website. Read more about how we use cookies and take care of your data here

Necessary/functional

Statistical

Accept
Back to Insights & Assignments

Deals and Assignments

See all Deals and Assignments

17 April 2024

Moalem Weitemeyer assists Dawn Capital

17 April 2024

Moalem Weitemeyer assists CNH Industrial

8 April 2024

Moalem Weitemeyer advises Blue Phoenix Group in the acquisition of RGS Nordic

5 April 2024

Moalem Weitemeyer assists XANO Industri

21 March 2024

Moalem Weitemeyer assists AaB

8 March 2024

Moalem Weitemeyer assists Kvanted Oy

22 February 2024

Moalem Weitemeyer assists People Ventures

16 February 2024

Moalem Weitemeyer assists DSV

15 February 2024

Moalem Weitemeyer assists Octopus Ventures and Ridge Ventures

13 February 2024

Moalem Weitemeyer advises Intermail

9 June 2020

Moalem Weitemeyer assisted Sass & Larsen

Moalem Weitemeyer assisted Sass & Larsen in the sale of the remaining 37% of shares in OV-SPV2 to Oncology Venture and subsequent SEK 36 million subscription of shares in Oncology Venture.

Oncology Venture is traded on First North GM Sweden, and with this investment the company now has full ownership and control of its priority program Dovitinib, a pan-tyrosine kinase inhibitor that has promising potential to improve cancer treatments.

On completion of the transaction, Sass & Larsen will own approx. 22% of Oncology Venture.

Henning Aasmul-Olsen

Partner

+45 30 37 96 50

Go to profile
Menu
Moalem Weitemeyer Advokatpartnerselskab

Amaliegade 3
DK-1256 Copenhagen 


TEL.       +45 7070 1505
CVR:      31 62 78 85

Reception opening hours

Monday to Thursday:
8 a.m.-6 p.m. 


Friday:
8 a.m.-5 p.m.

Legal Notices